26619808|t|APOE*E2 allele delays age of onset in PSEN1 E280A Alzheimer's disease.
26619808|a|Alzheimer's disease (AD) age of onset (ADAOO) varies greatly between individuals, with unique causal mutations suggesting the role of modifying genetic and environmental interactions. We analyzed ~50 000 common and rare functional genomic variants from 71 individuals of the 'Paisa' pedigree, the world's largest pedigree segregating a severe form of early-onset AD, who were affected carriers of the fully penetrant E280A mutation in the presenilin-1 (PSEN1) gene. Affected carriers with ages at the extremes of the ADAOO distribution (30s-70s age range), and linear mixed-effects models were used to build single-locus regression models outlining the ADAOO. We identified the rs7412 (APOE*E2 allele) as a whole exome-wide ADAOO modifier that delays ADAOO by ~12 years (beta=11.74, 95% confidence interval (CI): 8.07-15.41, P=6.31 x 10(-8), PFDR=2.48 x 10(-3)). Subsequently, to evaluate comprehensively the APOE (apolipoprotein E) haplotype variants (E1/E2/E3/E4), the markers rs7412 and rs429358 were genotyped in 93 AD affected carriers of the E280A mutation. We found that the APOE*E2 allele, and not APOE*E4, modifies ADAOO in carriers of the E280A mutation (beta=8.24, 95% CI: 4.45-12.01, P=3.84 x 10(-5)). Exploratory linear mixed-effects multilocus analysis suggested that other functional variants harbored in genes involved in cell proliferation, protein degradation, apoptotic and immune dysregulation processes (i.e., GPR20, TRIM22, FCRL5, AOAH, PINLYP, IFI16, RC3H1 and DFNA5) might interact with the APOE*E2 allele. Interestingly, suggestive evidence as an ADAOO modifier was found for one of these variants (GPR20) in a set of patients with sporadic AD from the Paisa genetic isolate. This is the first study demonstrating that the APOE*E2 allele modifies the natural history of AD typified by the age of onset in E280A mutation carriers. To the best of our knowledge, this is the largest analyzed sample of patients with a unique mutation sharing uniform environment. Formal replication of our results in other populations and in other forms of AD will be crucial for prediction, follow-up and presumably developing new therapeutic strategies for patients either at risk or affected by AD.
26619808	38	43	PSEN1	Gene	5663
26619808	44	49	E280A	ProteinMutation	tmVar:p|SUB|E|280|A;HGVS:p.E280A;VariantGroup:0;CorrespondingGene:5663;RS#:63750231;CorrespondingSpecies:9606;CA#:341491
26619808	50	69	Alzheimer's disease	Disease	MESH:D000544
26619808	71	90	Alzheimer's disease	Disease	MESH:D000544
26619808	92	94	AD	Disease	MESH:D000544
26619808	110	115	ADAOO	Disease	
26619808	434	436	AD	Disease	MESH:D000544
26619808	488	493	E280A	ProteinMutation	tmVar:p|SUB|E|280|A;HGVS:p.E280A;VariantGroup:0;CorrespondingGene:5663;RS#:63750231;CorrespondingSpecies:9606;CA#:341491
26619808	510	522	presenilin-1	Gene	5663
26619808	524	529	PSEN1	Gene	5663
26619808	588	593	ADAOO	Disease	
26619808	724	729	ADAOO	Disease	
26619808	749	755	rs7412	SNP	tmVar:rs7412;VariantGroup:2;CorrespondingGene:348;RS#:7412;CorrespondingSpecies:9606
26619808	795	800	ADAOO	Disease	
26619808	822	827	ADAOO	Disease	
26619808	980	984	APOE	Gene	348
26619808	986	1002	apolipoprotein E	Gene	348
26619808	1050	1056	rs7412	SNP	tmVar:rs7412;VariantGroup:2;CorrespondingGene:348;RS#:7412;CorrespondingSpecies:9606
26619808	1061	1069	rs429358	SNP	tmVar:rs429358;VariantGroup:1;CorrespondingGene:348;RS#:429358;CorrespondingSpecies:9606
26619808	1091	1093	AD	Disease	MESH:D000544
26619808	1119	1124	E280A	ProteinMutation	tmVar:p|SUB|E|280|A;HGVS:p.E280A;VariantGroup:0;CorrespondingGene:5663;RS#:63750231;CorrespondingSpecies:9606;CA#:341491
26619808	1220	1225	E280A	ProteinMutation	tmVar:p|SUB|E|280|A;HGVS:p.E280A;VariantGroup:0;CorrespondingGene:5663;RS#:63750231;CorrespondingSpecies:9606;CA#:341491
26619808	1464	1484	immune dysregulation	Disease	OMIM:614878
26619808	1502	1507	GPR20	Gene	2843
26619808	1509	1515	TRIM22	Gene	10346
26619808	1517	1522	FCRL5	Gene	83416
26619808	1524	1528	AOAH	Gene	313
26619808	1530	1536	PINLYP	Gene	390940
26619808	1538	1543	IFI16	Gene	3428
26619808	1545	1550	RC3H1	Gene	149041
26619808	1555	1560	DFNA5	Gene	1687
26619808	1643	1648	ADAOO	Disease	
26619808	1695	1700	GPR20	Gene	2843
26619808	1714	1722	patients	Species	9606
26619808	1737	1739	AD	Disease	MESH:D000544
26619808	1866	1868	AD	Disease	MESH:D000544
26619808	1901	1906	E280A	ProteinMutation	tmVar:p|SUB|E|280|A;HGVS:p.E280A;VariantGroup:0;CorrespondingGene:5663;RS#:63750231;CorrespondingSpecies:9606;CA#:341491
26619808	1995	2003	patients	Species	9606
26619808	2133	2135	AD	Disease	MESH:D000544
26619808	2235	2243	patients	Species	9606
26619808	2274	2276	AD	Disease	MESH:D000544
26619808	Positive_Correlation	MESH:D000544	RS#:429358;CorrespondingGene:348
26619808	Association	OMIM:614878	3428
26619808	Association	OMIM:614878	10346
26619808	Positive_Correlation	MESH:D000544	RS#:7412;CorrespondingGene:348
26619808	Association	OMIM:614878	313
26619808	Association	MESH:D000544	RS#:63750231;HGVS:p.E280A;CorrespondingGene:5663
26619808	Association	OMIM:614878	149041
26619808	Association	OMIM:614878	2843
26619808	Association	MESH:D000544	5663
26619808	Association	OMIM:614878	83416
26619808	Association	OMIM:614878	1687
26619808	Association	OMIM:614878	390940
26619808	Association	MESH:D000544	348
26619808	Association	MESH:D000544	5663

